Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Vaccine Regulation To Be Scrutinized By Senate Health Committee

Executive Summary

The Senate Health Committee will push for changes in FDA's approach to vaccine regulation, committee health counsel Steve Irizarre told the Banc of America healthcare forum Dec. 10 in New York

You may also be interested in...



Medicare Rx Positioning For 2003: Merck Prepares Investors For Benefit

Merck is telling investors to expect a "meaningful" Medicare prescription drug benefit in the 108th Congress

Lilly Says Thimerosal Provision Is Clarification Of Existing Law, Not Change

Thimerosal liability protection included in the Homeland Security legislation is a clarification of existing law rather than a change, Lilly says

Lilly Says Thimerosal Provision Is Clarification Of Existing Law, Not Change

Thimerosal liability protection included in the Homeland Security legislation is a clarification of existing law rather than a change, Lilly says

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS040943

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel